» Articles » PMID: 25853265

Design of an Osteoinductive Extracellular Fibronectin Matrix Protein for Bone Tissue Engineering

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2015 Apr 9
PMID 25853265
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Integrin-mediated cell-matrix interactions play an important role in osteogenesis. Here, we constructed a novel osteoinductive fibronectin matrix protein (oFN) for bone tissue engineering, designed to combine the integrin-binding modules from fibronectin (iFN) and a strong osteoinductive growth factor, bone morphogenetic protein-2. Compared with iFN, the purified oFN matrix protein caused a significant increase in cell adhesion and osteogenic differentiation of pre-osteoblast MC3T3-E1 cells (p < 0.05).

Citing Articles

Bio-functionalization and in-vitro evaluation of titanium surface with recombinant fibronectin and elastin fragment in human mesenchymal stem cell.

Park B, Jeong E, Lee S, Jang J PLoS One. 2021; 16(12):e0260760.

PMID: 34914752 PMC: 8675760. DOI: 10.1371/journal.pone.0260760.


Synthesis and Characterization of Polymer-Based Coatings Modified with Bioactive Ceramic and Bovine Serum Albumin.

Florkiewicz W, Slota D, Placek A, Pluta K, Tyliszczak B, Douglas T J Funct Biomater. 2021; 12(2).

PMID: 33808394 PMC: 8103286. DOI: 10.3390/jfb12020021.


Bone Matrix Non-Collagenous Proteins in Tissue Engineering: Creating New Bone by Mimicking the Extracellular Matrix.

Carvalho M, Cabral J, da Silva C, Vashishth D Polymers (Basel). 2021; 13(7).

PMID: 33808184 PMC: 8036283. DOI: 10.3390/polym13071095.


Enhancing effects of basic fibroblast growth factor and fibronectin on osteoblast adhesion to bone scaffolds for bone tissue engineering through extracellular matrix-integrin pathway.

Feng L, Li Y, Zeng W, Xia B, Zhou D, Zhou J Exp Ther Med. 2017; 14(6):6087-6092.

PMID: 29285162 PMC: 5740605. DOI: 10.3892/etm.2017.5320.

References
1.
Lecanda F, Avioli L, Cheng S . Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem. 1997; 67(3):386-96. View

2.
Choung P, Seo B, Chung C, Yamada K, Jang J . Synergistic activity of fibronectin and fibroblast growth factor receptors on neuronal adhesion and neurite extension through extracellular signal-regulated kinase pathway. Biochem Biophys Res Commun. 2002; 295(4):898-902. DOI: 10.1016/s0006-291x(02)00774-x. View

3.
Jeon E, Yun Y, Kim H, Jang J . Engineering and application of collagen-binding fibroblast growth factor 2 for sustained release. J Biomed Mater Res A. 2013; 102(1):1-7. DOI: 10.1002/jbm.a.34689. View

4.
Oldberg A, Linney E, Ruoslahti E . Molecular cloning and nucleotide sequence of a cDNA clone coding for the cell attachment domain in human fibronectin. J Biol Chem. 1983; 258(17):10193-6. View

5.
Govender S, Csimma C, Genant H, Valentin-Opran A, Amit Y, Arbel R . Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84(12):2123-34. DOI: 10.2106/00004623-200212000-00001. View